The xanthine oxidase inhibitor allopurinol has been shown to normalize endothelial dysfunction in individuals with Type 2 diabetes and reduce lipid peroxidation and the formation of reactive oxygen species [273]. This evidence concerns the gene XDH and type 2 diabetes mellitus.